[{"Assets_0_Q1_USD":253183000.0,"CommonStockSharesOutstanding_0_Q1_shares":41269643.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-31318000.0,"NetIncomeLoss_1_Q1_USD":-37565000.0,"StockholdersEquity_0_Q1_USD":182253000.0,"Ticker":"ACRS","CIK":"1557746","name":"ACLARIS THERAPEUTICS, INC.","OfficialName":"Aclaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1075670582.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]